Monographie - Ganciclovir sodium

Cập nhật lần cuối :
29/10/2024

Ganciclovir sodium

Cấu trúc hóa học

Tên thương mại

Các tên thương mại được cung cấp và thành phần tá dược có thể khác nhau giữa các quốc gia và các hãng dược

Ceptyl	Mexico
Ciganclor	Argentina
Citovirax	Ý
Cymevan	Pháp
Cymeven	Đức
Cymevene	Ả Rập, Anh, Áo, Ba Lan, Bỉ, Bồ Đào Nha, Brazil, Chile, Colombia, Croatia, Ecuador, Hà Lan, Hungary, Hy Lạp, Iceland, Iran, Ireland, Luxembourg, Malaysia, Mexico, Na Uy, new zealand, Nga, Peru, Phần Lan, Tây Ban Nha, Thổ Nhĩ Kỳ, Thụy Sỹ, Thụy Điển, Úc, United Arab Emirates, Venezuela, Ý, Đan Mạch
Cymevir	Brazil
Cytovene	Canada, Hoa Kỳ
Ganciclovir	Argentina, Canada, Chile, Ecuador, Hoa Kỳ, Mexico, Pháp, Đức
Gavir	Ấn Độ
Inglav	Mexico
Natclovir	Ấn Độ
Pharcigave	Mexico
Umecortil	Colombia, Mexico
Viraprex	Mexico

Tài liệu tham khảo : Ganciclovir sodium

	Loại	Nguồn
3	Tạp chí	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
4	Tạp chí	Zazempa V, Morgenszejn J, Paul M, Astier A. Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité. Act Pharm Biol Clin 1995 ; 8: 525-528.
36	Tạp chí	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
59	Tạp chí	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
67	Tạp chí	Outman WR, Mitrano FP, Baptista RJ. Visual compatibility of ganciclovir sodium and parenteral nutrient solution during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 1538-1539.
69	Tạp chí	Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA. Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 2810-2812.
70	Tạp chí	Silvestri AP, Mitrano FP, Baptista RJ, Williams DA. Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Am J Hosp Pharm 1991 ; 48: 2641-2643.
72	Tạp chí	Johnson CE, Jacobson PA, Chan E. Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions. Am J Hosp Pharm 1994 ; 51: 503-508.
73	Tạp chí	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
74	Tạp chí	Mulye NV, Turco SJ, Speaker TJ. Stability of ganciclovir sodium in an infusion-pump syringe. Am J Hosp Pharm 1994 ; 51: 1348-1349.
76	Tạp chí	Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA. Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days. Am J Hosp Pharm 1992 ; 49: 116-118.
81	Tạp chí	Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 672-678.
84	Tạp chí	Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 495-499.
88	Tạp chí	Mole L, Oliva C, O?Hanley P. Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis. J Acquired Immune Defic Syndr 1992 ; 5: 354-358.
99	Tạp chí	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169	Tạp chí	Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363.
182	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
201	Tạp chí	Thompson DF, Allen LV, Stiles ML. Visual compatibility of enalaprilate with selected intravenous medications during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 2530-2531.
244	Tạp chí	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
245	Tạp chí	Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman M. Stability of ganciclovir sodium (Cymevan*) after dilution in PVC infusions and polypropylene syringes. J Pharm Belg 1992 ; 47: 494-498.
248	Tạp chí	Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993 ; 50: 300-304.
249	Tạp chí	Trissel LA, Martinez JF. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
253	Tạp chí	Trissel LA, Chandler SW, Folstad JT. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1990 ; 47: 2525-2528.
299	Tạp chí	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301	Tạp chí	Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
307	Tạp chí	Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1792-1799.
334	Tạp chí	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	Tạp chí	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
479	Tạp chí	Min DI, Brown T, HWang GC. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 2964-2966.
492	Tạp chí	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.
496	Tạp chí	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Thông tin của nhà sản xuất	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
905	Tạp chí	Trissel LA, Martinez JF. Screening teniposide for Y-site physical incompatibilities. Hosp Pharm 1994 ; 29: 1010-1017.
921	Tạp chí	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1410	Tạp chí	Trissel LA, Martinez JF, Simmons M. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 141-145.
1415	Tạp chí	Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN 1999 ; 23: 67-74.
1423	Tạp chí	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1625	Tạp chí	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1754	Tạp chí	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1925	Tạp chí	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Tạp chí	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Tạp chí	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2247	Tạp chí	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
3626	Thông tin của nhà sản xuất	Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit Astellas Pharma 2014
3662	Thông tin của nhà sản xuất	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
3728	Tạp chí	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3791	Poster	Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P. Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y. Apifh Congress, Paris November 2014 2014
3796	Tạp chí	Morlet N, Young S, Naidoo D et al. High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study. Br Ophtalmol 1995 ; 79: 753-755.
3883	Thông tin của nhà sản xuất	Ceftazidime - Résumé des caractéristiques du produit Arrow 2016
4021	Tạp chí	Guichard N, Bonnabry P, Rudaz S, Fleury S. Long-term stability of ganciclovir in polypropylene containers at room temperature. J Oncol Pharm Practice 2017 ;25,2: 303-308
4521	Tạp chí	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020

Mentions Légales